These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1414039)

  • 21. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy.
    Esper JJ; Nigro MA; Wishnow R; Barnett T; Perrotta AL; Richardson W
    J Am Osteopath Assoc; 1992 Aug; 92(8):1056-8. PubMed ID: 1429067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axonal neuropathy in eosinophilia-myalgia syndrome.
    Burns SM; Lange DJ; Jaffe I; Hays AP
    Muscle Nerve; 1994 Mar; 17(3):293-8. PubMed ID: 8107705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients.
    Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ
    Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
    Bournerias I; Castot A
    Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247
    [No Abstract]   [Full Text] [Related]  

  • 25. Microangiopathy in the eosinophilia-myalgia syndrome.
    Smith SA; Roelofs RI; Gertner E
    J Rheumatol; 1990 Nov; 17(11):1544-50. PubMed ID: 2273500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
    Suzuki S; Tourkina E; Ludwicka A; Hampton M; Bolster M; Maize J; Silver R
    Proc Assoc Am Physicians; 1996 Jul; 108(4):315-22. PubMed ID: 8863345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
    Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
    Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-tryptophan-induced eosinophilia-myalgia syndrome. I. Report of two cases with pseudoxanthoma-elasticum-like skin changes.
    Mainetti C; Schmied E; Masouyé I; Chavaz P; Saurat JH
    Dermatologica; 1991; 183(1):57-61. PubMed ID: 1769422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleroderma-like fasciitis without eosinophilia after L-tryptophan ingestion.
    Schlessel K; Greenwald R; Hirschfield L
    J Rheumatol; 1991 May; 18(5):779-82. PubMed ID: 1865433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
    Sidransky H
    Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
    Frick P; Frey R
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1633-5. PubMed ID: 2251478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan-induced eosinophilia-myalgia syndrome.
    Criswell LA; Sack KE
    West J Med; 1990 Sep; 153(3):269-74. PubMed ID: 2219890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Demyelinating nervous lesions in myalgia-eosinophilia syndrome induced by L Tryptophan].
    Labauge P; Moulonguet A; Penaud D; Lessana-Leibowitch M; Kahn MF; Said G
    Rev Neurol (Paris); 1993; 149(4):278-82. PubMed ID: 8235226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic myositis an expression of L-tryptophan toxicity?
    Estrada CA; Harrington DW; Glasberg MR
    J Rheumatol; 1990 Nov; 17(11):1554-6. PubMed ID: 2273502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
    Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
    Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilia-myalgia syndrome associated with L-tryptophan use.
    Glickstein SL; Gertner E; Smith SA; Roelofs RI; Hathaway DE; Schlesinger PA; Schned ES
    J Rheumatol; 1990 Nov; 17(11):1534-43. PubMed ID: 2273499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine.
    Mainetti C; Fathi M; Saurat JH
    Dermatologica; 1991; 183(1):62-5. PubMed ID: 1722762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.